Dr. Calvin Ke* (pronounced “key”) is an Assistant Professor in the Department of Medicine, University of Toronto, a clinician scientist at the Toronto General Hospital Research Institute, an adjunct scientist at ICES, and a staff endocrinologist at the Toronto General Hospital, University Health Network in Toronto, Canada. He leads the Health Services and Quality of Care Working Group of the Novo Nordisk Network for Healthy Populations at the University of Toronto. He received his Doctor of Medicine from the University of Toronto. He completed his residency training in Internal Medicine at the University of British Columbia and Endocrinology and Metabolism at the University of Toronto. He completed his PhD in clinical epidemiology and global health as a Global Scholar at the Institute of Health Policy, Management and Evaluation, University of Toronto. He has conducted diabetes research internationally across Canada, China, India, and Guyana. His research interests include the management and outcomes of type 2 diabetes, with a focus on young-onset type 2 diabetes and on Chinese and South Asian populations. He is a member of the International Diabetes Federation Atlas Committee and the NCD Risk Factor Collaboration. He served as an Honorary Visiting Scholar at The Chinese University of Hong Kong. He has published peer-reviewed research articles in high-impact journals such as JAMA, Annals of Internal Medicine, The Lancet Global Health, PLoS Medicine, and Nature Reviews Endocrinology. He is a recipient of multiple awards including the Canadian Society of Endocrinology and Metabolism Dr. Fernand Labrie Fellowship Research Award, the Queen Elizabeth Advanced Scholars Award, and the South Asian Network Supporting Awareness and Research Burgundy Young Investigator Award. He is the lead endocrinologist of the Diabetic Kidney Disease Clinic at Scarborough Health Network and provides clinical outreach services for Chinese and other diverse communities with the CareFirst Family Health Team.